Erythromycin propionate

• Description:

  Erythromycin propionate, erythromycin (HY-B0220) derivative[1], is a macrolide antibiotic used in the treatment of a wide variety of bacterial infections. Erythromycin propionate causes several cases of liver injury which mostly include cholestatic hepatitis. Erythromycin propionate toxicity is related to its inhibitory effect on bile acid transport[2].

• UNSPSC:

  12352005

• Target:

  Aminotransferases (Transaminases) ; Antibiotic; Bacterial; Dengue Virus; Flavivirus

• Related Pathways:

  Anti-infection; Metabolic Enzyme/Protease

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Smiles:

  CCC(O[C@H]([C@H](C[C@H](O1)C)N(C)C)[C@@H]1O[C@@H]2[C@H]([C@@H]([C@H](C(O[C@@H]([C@@](O)([C@@H]([C@H](C([C@@H](C[C@]2(O)C)C)=O)C)O)C)CC)=O)C)O[C@H]3C[C@](C)([C@H]([C@@H](O3)C)O)OC)C)=O

• Molecular Formula:

  C40H71NO14

• Molecular Weight:

  789.99

• References & Citations:

  [1]Zimmerman HJ, et al. Studies on the vitro cytotoxicity of erythromycin estolate. Proc Soc Exp Biol Med. 1973 Dec;144 (3) :759-61.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [134-36-1]